Biotech

All Articles

Otsuka spends $800M for Jnana and its clinical-stage PKU drug

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 million so the Oriental bio...

FibroGen gives up 75% of US workers as property flunks 2 even more tests

.FibroGen is actually drastically restructuring its organization, laying off 75% of its USA staff as...

Tracon winds down full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually determined to wind down procedures full weeks after an injectab...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy drug, touts FDA run

.Our experts already know that Takeda is hoping to locate a course to the FDA for epilepsy medicatio...

VBI Vaccinations apply for insolvency, seeks property purchase

.Immunology biotech VBI Injections is drifting dangerously near to the moment of truth, along with p...

Celldex anti-cKIT antibody lower hives in another phase 2 study

.It's not easy to muscle in on a room as affordable as immunology, yet Celldex Therapeutics strongly...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Therapeutics and a preclinical...

Ventyx's last hope for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's illness medication carried out certainly not help clients obtain remiss...

Cognition's stage 2 sparkle data taint Alzheimer's prospect

.Knowledge Therapeutics' period 2 sparkle trial has actually taken some of the radiance off the Alzh...